INS and Alzheimer disease: As a reduced glucose uptake and glycogen synthesis in astrocytes would impair the neuronal function, it is reasonable to hypothesize that a persistent and progressive brain metabolic alteration (brain insulin resistance and the related disruption of energy supply) would trigger neurodegeneration, altering a signaling cascade and promoting the AD pathologic changes and amyloid-β (Aβ) deposition [44].